Several studies identified molecules associated with the tumor escape mechanism, such as PD-1/PD-L1, Fas/ FasL, and Decoy receptor 3, which might explain the poor immunogenicity and limitations of the antitumor effects of cancer vaccines alone in patients with advanced HCC (16,17,34,35). Here, TNFRSF6B is linked to neoplasm.